Silence Therapeutics plc Finance Costs
Silence Therapeutics plc (SLN) reported Finance Costs of GBP 2.15 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:FinanceCosts · last filed 2024-03-13
| Period end | Finance Costs 12 month |
|---|---|
| 2023-12-31 | 2.15M GBP 20-F · filed 2024-03-13 |
| 2022-12-31 | 47.00K GBP 20-F · filed 2024-03-13 |
| 2021-12-31 | 52.00K GBP 20-F · filed 2024-03-13 |
| 2020-12-31 | 323.00K GBP 20-F · filed 2023-03-15 |
| 2019-12-31 | 163.00K GBP 20-F · filed 2022-03-17 |